Welcome to our dedicated page for Koninklijke Phil news (Ticker: PHG), a resource for investors and traders seeking the latest updates and insights on Koninklijke Phil stock.
Koninklijke Philips N.V. reports health technology developments across Diagnosis & Treatment, Connected Care and Personal Health. News from Royal Philips commonly covers order intake and comparable sales trends; product launches and regulatory clearances for imaging, image-guided therapy and AI software; and governance actions from its Annual General Meeting. Recent product themes include CT platforms such as Rembra and Spectral CT Verida, interventional guidance tools such as DeviceGuide and IntraSight Plus, and the Bridge Plus Occlusion Balloon for lead extraction procedures.
The company’s updates also address hospital monitoring, informatics, ultrasound, oral health and personal-care lines. Coverage reflects Philips’ role as a Netherlands-based global health technology company with securities traded on NYSE under PHG and on Euronext Amsterdam under PHIA.
Philips (NYSE: PHG) and Ingeborg Initiatives have partnered to provide Arkansas expectant parents with access to the Philips Avent Pregnancy+ app, featuring customized state-specific content and resources. The initiative aims to address Arkansas's critical maternal health challenges, as the state ranks 50th in both maternal and infant mortality rates.
The Pregnancy+ app, which has over 80 million lifetime downloads, offers comprehensive pregnancy guidance including 800+ articles, 3D baby models, weekly pregnancy tracking, and expert-led courses. Arkansas residents will receive premium access to state-specific information about social services, infant health, mental health resources, and early childhood programs.
A recent survey indicates that Pregnancy+ app users demonstrate higher maternal health literacy and increased engagement in prenatal care compared to non-users. The collaboration represents a multi-stakeholder approach to improving maternal health outcomes in Arkansas through accessible digital resources.
Philips has selected AWS as its preferred cloud provider to enhance its healthcare informatics solutions globally. Over the past 12 months, Philips has supported 34 million patient exams in the cloud and manages 134 petabytes of data, including 11 billion medical images, with plans to scale to one exabyte by 2030.
Key achievements include deploying solutions across 200+ healthcare sites globally, reducing infrastructure costs by 36%, and connecting 1.3 million IoT devices to the cloud. Philips launched the Tasy EMR AI Virtual Assistant powered by Amazon Bedrock for automated patient data capture and is exploring generative AI capabilities to address healthcare staff shortages.
The partnership aims to accelerate healthcare digital transformation through AI-enabled workflows in radiology, digital pathology, cardiology, and advanced visualization solutions.
Philips (NYSE: PHG) announced the expansion of its cloud-based radiology informatics solutions to Europe, following successful deployment in over 150 sites across the Americas. The HealthSuite Imaging platform, hosted on Amazon Web Services (AWS), offers a software-as-a-service model with regular upgrades and security features.
The cloud service will be available in 13 European countries, pending regulatory approval from DEKRA. The platform enables secure, remote access to radiology exams, AI-enabled workflows, and integrated reporting capabilities. Philips is also exploring generative AI applications through Amazon Bedrock for conversational reporting to address clinical demands and workforce shortages.
According to industry data, 95% of healthcare providers plan to migrate over half of their applications to the cloud within three years. The solution aims to enhance collaboration, accelerate clinical decisions, and improve operational efficiency while reducing IT management burdens.
Philips has unveiled significant AI-driven advancements in MRI technology, introducing SmartSpeed Precise with Dual-AI engines. This innovation enables up to 3x faster scanning while delivering 80% improved image sharpness. The company also launched MR Workspace R12 software featuring 'zero-click' workflow and AI-powered SmartExam that automates 80% of MR procedures.
The company showcased its next-generation helium-free 1.5T BlueSeal wide-bore scanner at ECR 2025, emphasizing sustainability in medical imaging. Since 2018, Philips BlueSeal technology has conserved nearly 5 million liters of liquid helium and reduces energy consumption by approximately 40 MWh annually per system. With over 1,500 installations worldwide, the technology demonstrates significant environmental impact reduction while maintaining high-performance imaging capabilities.
Philips (NYSE: PHG) has partnered with Amerigroup, CareSource Georgia, and Peach State Health Plan to launch a remote monitoring program for high-risk pregnancies in Georgia. The initiative, supporting the Georgia Healthy Babies Act, will initially cover 50 counties, focusing on pregnant and postpartum individuals with maternal hypertension and diabetes.
The program allows Medicaid-covered pregnant women to receive monitoring devices and personalized health coaching from Philips' licensed nurses, dietitians, and diabetes care specialists. The service includes real-time alerts for out-of-range readings and continues up to 90 days postpartum.
This initiative addresses critical healthcare challenges in Georgia, where Medicaid covers nearly 50% of births and the state ranks 31st of 40 in maternal mortality. The program is particularly significant given that 62% of U.S. pregnancies are identified as high-risk, with an 81.3% increase in hypertension and 50% in diabetes cases. Additionally, over 35% of US counties are classified as maternity care deserts.
Philips (NYSE: PHG, AEX: PHIA) has published its Annual Report 2024, which will be discussed at the Annual General Meeting of Shareholders (AGM) scheduled for May 8, 2025. The company has filed the report with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and plans to file Form 20-F with the U.S. Securities and Exchange Commission.
The Annual Report 2024 is accessible to shareholders and interested parties at www.results.philips.com, with printed copies available upon request via annual.report@philips.com.
Philips (NYSE: PHG) and Mass General Brigham (MGB) announced a collaboration to develop and deploy advanced data infrastructure and AI for improving patient care. The partnership aims to create a unified, near real-time data and insights ecosystem by integrating live healthcare data from multiple sources.
The collaboration will utilize Philips technologies including Capsule Medical Device Information Platform, Clinical Insights Manager, and Capsule Surveillance to combine data from bedside medical devices with longitudinal clinical data. The system will enable continuous algorithmic processing to deliver smart alerts into live clinical practice.
An initial research program focuses on patients under continuous heart monitoring, aiming to improve early detection of cardiac events. The joint effort combines MGB's biomedical engineering, clinical specialists, and AI expertise with Philips' research capabilities to develop new algorithms for identifying patient-cohort patterns and generating actionable clinical insights.
Philips (NYSE: PHG) announced changes to its Supervisory Board and Board of Management. David Pyott will retire after serving three consecutive terms since 2015. The company proposed Bob White, former Executive Vice President at Medtronic, as a new Supervisory Board member and future Chair of the Quality & Regulatory Committee.
The company also proposed reappointments of Indra Nooyi and Chua Sock Koong to the Supervisory Board, citing their valuable contributions in areas including consumer products, technology, digitization, and financial expertise. Additionally, Marnix van Ginneken was proposed for reappointment to the Board of Management.
The Annual General Meeting of Shareholders will be held on May 8, 2025, where these appointments will be considered.
Philips reported its Q4 and 2024 financial results, showing growth and improved profitability. Key highlights include:
Sales reached EUR 18.0 billion in 2024 with 1% comparable growth, despite significant decline in China. The company achieved an Adjusted EBITA margin increase of 90 basis points to 11.5% in 2024, and generated EUR 906 million in free cash flow.
Notable developments include finalization of Respironics recall-related settlements in US, maintained dividend at EUR 0.85 per share, and increased productivity savings target from EUR 2 billion to EUR 2.5 billion for 2023-2025. For 2025, Philips projects 1-3% comparable sales growth, with China expecting mid to high-single-digit decline.
The company strengthened its innovation pipeline with FDA clearances for new CT systems and expanded collaboration with Amazon Web Services for cloud-based diagnostics solutions.
Philips (NYSE: PHG) has announced a major healthcare initiative in Ukraine in collaboration with the World Bank and Ukraine's Ministry of Health. The program aims to modernize stroke and cardiovascular care across the country by establishing an advanced nationwide acute stroke treatment network.
The initiative includes the deployment of 25 Azurion interventional suites for minimally invasive stroke treatments, with 19 systems already installed in key regions including Dnipro, Sumy, Kharkiv, Lviv, Zaporizhzha and Odesa. These systems support complex neurovascular procedures like thrombectomies and integrate software tools to enhance care coordination.
The program addresses Ukraine's growing stroke care demand, which is nearly doubling due to war damage and displaced populations. Approximately 140,000 Ukrainians experience stroke annually. The initiative also includes comprehensive clinical training for physicians in Poland to ensure optimal utilization of the new stroke network.